Icon, a company creating a new paradigm for bringing clinical research to patients, has agreed to acquire PRA Health Sciences Inc. in a cash and stock transaction valued at approximately $12 billion.   The consolidation brings together two growing organizations with similar cultures and values to create a leading healthcare intelligence and clinical CRO. Their combined focus will be on applying transformational technology and innovation to execute clinical trials from Phase 1 to post-approval st...